Tianjin Pharmaceutical Da Ren Tang Group unit Tianjin Pharmaceutical Group Finance, a non-bank financial institution, plans to increase its registered capital from 500 million yuan to 1 billion yuan to meet regulatory requirements, according to a Friday filing on the Singapore Exchange.
This follows Tianjin Pharmaceutical Holdings (TPH) acquiring an additional 15% stake in Tianjin Pharmaceutical Group Finance, raising its ownership to 30%.
To comply with financial regulations, Tianjin Pharmaceutical Group Finance's shareholders, including Tianjin Pharmaceutical Holdings, the company, Tianjin Yaoye, and Tianjin Jin Yi Investment, have agreed to a proportional capital increase.
Tianjin Pharmaceutical Group Finance will contribute 150 million yuan, about 2.3% of its latest audited net tangible assets of 6.53 billion yuan.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。